Arch Therapeutics Receives ISO 13485 Certification for AC5

FRAMINGHAM, MA ARTH, (Marketwired Mar 9, 2016) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of the AC5 Surgical Hemostatic Device™ ( AC5™ ), today announces that it has received an internationally recognized ISO quality certification, marking completion of a critical step for Arch in its plans to commercialize AC5. The certification, which was awarded by British Standards Institution Group America, Inc., attests that the Company s quality management system complies with the requirements of ISO 13485:2003 for the design and manufacture of AC5 for hemostasis. ISO 13485 is a quality management system standard accepted as the basis for CE marking medical devices under European Directives. ISO 13485:2003 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devic


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: